Rachel Sharpe

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 738 citations · Full text

Medicine, Cancer Biology, Oncology +17

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Nicholas C. Turner, Maryou B. Lambros, Hugo M. Horlings et al. · Oncogene · 2010 · 412 citations · Full text

Medicine, Molecular Biology, Oncology +16

Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1

Marieke Aarts, Rachel Sharpe, Isaac García-Murillas et al. · Cancer Discovery · 2012 · 329 citations

Life Sciences, Cancer Biology, Oncology +17

The size, burden and cost of disorders of the brain in the UK

Naomi Fineberg, Peter Haddad, Lewis Carpenter et al. · Journal of Psychopharmacology · 2013 · 216 citations · Full text

Medicine, Psychiatry, Cost-effectiveness Analysis +6

FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both <i>In Vitro</i> and <i>In Vivo</i>

Rachel Sharpe, Alex Pearson, María Teresa Herrera-Abreu et al. · Clinical Cancer Research · 2011 · 167 citations · Full text

Life Sciences, Molecular Biology, Oncology +17